Detalhe da pesquisa
1.
The European Medicines Agency Review of Kymriah (Tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma.
Oncologist
; 25(2): e321-e327, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32043764